(Press-News.org) CORVALLIS, Ore. – Researchers at Oregon State University today announced the discovery of an underlying genetic cause of atopic dermatitis, a type of eczema most common in infancy that also affects millions of adults around the world with dry, itchy and inflamed skin lesions.
The findings were just published in PLoS ONE, a professional journal, and may set the stage for new therapeutic approaches to this frustrating syndrome, which is difficult to treat and has no known cure. Eczema is also related to, and can sometimes cause asthma, a potentially deadly immune dysfunction.
Pharmaceutical scientists at OSU found in laboratory studies that eczema can be triggered by inadequate Ctip2, a protein and master regulator that affects other genetic functions. They have identified two ways in which improper function of Ctip2 can lead to eczema.
In a recent publication, they found that Ctip2 controls lipid biosynthesis in the skin, the fats that are needed to help keep skin healthy and hydrated. In the new study, they discovered that Ctip2 suppresses TSLP, a cytokine protein produced by skin cells that can trigger inflammation.
Levels of this inflammatory TSLP, which is ordinarily undetectable in human skin, were found to be 1,000 times higher in laboratory animals that had been genetically modified to have no Ctip2 production in their skin.
"In these studies, we've basically shown that inadequate Ctip2 is reducing the lipids in skin that it needs to stay healthy, protect itself and perform its function," said Arup Indra, an associate professor in the OSU College of Pharmacy. "At the same time this can allow unwanted formation of proteins that trigger inflammation. The skin's ability to resist inflammation is going down just as the amount of inflammation is going up, and the underlying reason is that Ctip2 is not doing its job."
"Either or both of these problems can lead to eczema," Indra said.
Atopic dermatitis is associated with a dysfunctional immune response, but researchers have never understood the underlying cause. Existing treatments use moisturizers to try to protect skin, and in difficult cases powerful steroid drugs can help, but they often have significant unwanted side effects, especially in long-term use.
"With a better understanding of just what is causing eczema on a genetic basis, we should be able to personalize treatments, determine exactly what each person needs, and develop new therapies," Indra said. "This might be with topical compounds that increase Ctip2 expression in skin cells, or customized treatments to restore an individual person's lipid profile. In the future, systemic epigenetic modification might even be possible."
The creation at OSU of the laboratory model to study this issue is also of considerable importance, Indra said. There's evidence it could be used to screen for drugs with potent anti-inflammatory activities.
Eczema is a persistent skin rash that can be fairly common in infants or youth, which some research indicates may be linked to food or pollen allergens. Most people outgrow it as they reach adulthood, but some suffer from the debilitating condition their entire life.
"Our skin is the largest organ in the human body and one of the most important," Indra said. "It's our first barrier of defense, is in a constant battle against external insults, is influenced by both genetics and the environment, and has to be finely tuned to do many jobs. In eczema, this process begins to break down."
Eczema allows significant loss of fluids through the skin, allows allergens to penetrate, and in severe cases can cause a systemic inflammatory response.
### This research was supported by the National Institutes of Health.
Editor's Note: Digital photos are available to illustrate this story:
Normal skin: http://www.flickr.com/photos/oregonstateuniversity/8293697949/in/photostream
Inflamed skin: http://www.flickr.com/photos/oregonstateuniversity/8294761086/in/photostream
The publication this story is based on is available online at http://bit.ly/VUy4Im
Researchers discover genetic basis for eczema, new avenue to therapies
2012-12-21
ELSE PRESS RELEASES FROM THIS DATE:
Extending steroid treatment does not benefit children with hard-to-treat kidney disease
2012-12-21
Highlights
Six months of steroid treatment in children with nephrotic syndrome did not reduce relapse rates or side effects compared with three months of treatment.
Because many children with nephrotic syndrome face frequent relapses, future research should focus on preventing relapses through new treatment strategies.
Nephrotic syndrome has an estimated incidence of two to seven cases per 100,000 children and a prevalence of nearly 16 cases per 100,000.
Washington, DC (December 20, 2012) — Extending steroid treatment for the most common form of kidney disease ...
New target for treating prediabetes in patients with kidney disease
2012-12-21
Highlights
Retention of certain compounds that are normally excreted by the kidneys may cause insulin resistance, or prediabetes, in kidney disease patients.
When mice with kidney disease were treated with a prebiotic that reduces blood levels of these compounds, insulin resistance and lipid abnormalities were prevented.
Washington, DC (December 20, 2012) —Insulin resistance, or prediabetes, in individuals with kidney disease may be caused by the progressive retention of certain compounds that are normally excreted by the kidneys in healthy individuals, ...
Science's Breakthrough of the Year: Discovery of the Higgs boson
2012-12-21
The observation of an elusive sub-atomic particle, known as the Higgs boson, has been heralded by the journal Science as the most important scientific discovery of 2012. This particle, which was first hypothesized more than 40 years ago, holds the key to explaining how other elementary particles (those that aren't made up of smaller particles), such as electrons and quarks, get their mass.
In addition to recognizing the detection of this particle as the 2012 Breakthrough of the Year, Science and its international nonprofit publisher, AAAS, have identified nine other ...
Wallace's century-old map of natural world updated
2012-12-21
Until today, Alfred Russell Wallace's century old map from 1876 has been the backbone for our understanding of global biodiversity. Thanks to advances in modern technology and data on more than 20,000 species, scientists from University of Copenhagen have now produced a next generation map depicting the organisation of life on Earth. Published online in Science Express today, the new map provides fundamental information regarding the diversity of life on our planet and is of major significance for future biodiversity research.
An essential question in understanding life ...
Unlocking new talents in nature
2012-12-21
PASADENA, Calif.—Protein engineers at the California Institute of Technology (Caltech) have tapped into a hidden talent of one of nature's most versatile catalysts. The enzyme cytochrome P450 is nature's premier oxidation catalyst—a protein that typically promotes reactions that add oxygen atoms to other chemicals. Now the Caltech researchers have engineered new versions of the enzyme, unlocking its ability to drive a completely different and synthetically useful reaction that does not take place in nature.
The new biocatalysts can be used to make natural products—such ...
To outsmart malarial drug resistance, research team develops new whole-plant strategy
2012-12-21
AMHERST, Mass. – Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it. Resistance has cut short the useful life of nearly every therapy tried so far, experts say.
But now molecular parasitologist Stephen Rich at the University of Massachusetts Amherst has led a research team who report a promising new low-cost combined therapy with a ...
New MRI analysis useful in predicting stroke complications caused by clot-busters
2012-12-21
Johns Hopkins researchers have developed a new way of looking at standard MRI scans that more accurately measures damage to the blood-brain barrier in stroke victims, a process they hope will lead to safer, more individualized treatment of blood clots in the brain and better outcomes.
The blood-brain barrier is a unique shielding of blood vessels that limits the passage of molecules from the blood stream into the brain. Without it, the brain is open to infection, inflammation and hemorrhage. Ischemic stroke patients are at risk of bleeding into the brain when there is ...
Research reveals new drug target urgently needed for tuberculosis therapy
2012-12-21
One third of the world is infected with the bacterium that causes tuberculosis (TB), a disease that is increasingly difficult to treat because of wide spread resistance to available drugs. Researchers from the Institute of Pharmacology and Structural Biology (CNRS, Université de Toulouse) in Toulouse (France) have identified a fresh target to develop new drugs for TB. The study, published in the Open Access journal PLOS Pathogens, shows why the target will be important in developing new TB treatments.
The deadliest form of human tuberculosis is caused by Mycobacterium ...
Brain imaging insight into cannabis as a pain killer
2012-12-21
The pain relief offered by cannabis varies greatly between individuals, a brain imaging study carried out at the University of Oxford suggests.
The researchers found that an oral tablet of THC, the psychoactive ingredient in cannabis, tended to make the experience of pain more bearable, rather than actually reduce the intensity of the pain.
MRI brain imaging showed reduced activity in key areas of the brain that substantiated the pain relief the study participants experienced.
'We have revealed new information about the neural basis of cannabis-induced pain relief,' ...
Microevolutionary analysis of Clostridium difficile genomes to investigate transmission
2012-12-21
Over recent years, hospital-acquired Clostridium difficile infections have been a significant problem in UK hospitals and globally. There have been concerns that infections may be due to transmission between symptomatic patients, either directly, or indirectly via hospital staff; these concerns were strengthened when enhanced infection control was introduced in England in 2007, and the incidence of C. difficile infection declined. A recent study published in the open access journal Genome Biology, published by BioMed Central, took a genomics approach to assess the incidence ...